Cargando…

Targeting NF-κB in glioblastoma: A therapeutic approach

Glioblastoma multiforme (GBM) is the most common and lethal form of intracranial tumor. We have established a lentivirus-induced mouse model of malignant gliomas, which faithfully captures the pathophysiology and molecular signature of mesenchymal human GBM. RNA-Seq analysis of these tumors revealed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Friedmann-Morvinski, Dinorah, Narasimamurthy, Rajesh, Xia, Yifeng, Myskiw, Chad, Soda, Yasushi, Verma, Inder M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2016
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730860/ https://www.ncbi.nlm.nih.gov/pubmed/26824076 http://dx.doi.org/10.1126/sciadv.1501292

Ejemplares similares

Monocyte-neutrophil entanglement in glioblastoma
por: Friedmann-Morvinski, Dinorah, et al.
Publicado: (2023)

Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation
por: Hirbe, Angela C., et al.
Publicado: (2016)

Antibody Delivery into the Brain by Radiosensitizer Nanoparticles for Targeted Glioblastoma Therapy
por: Gal, Omer, et al.
Publicado: (2022)

Organelle‐Targeted BODIPY Photocages: Visible‐Light‐Mediated Subcellular Photorelease
por: Kand, Dnyaneshwar, et al.
Publicado: (2019)

Isolation and characterization of the immune cell fraction from murine brain tumor microenvironment
por: Mastandrea, Ignacio, et al.
Publicado: (2022)

The NFκB pathway: a therapeutic target in glioblastoma
por: Nogueira, Lorena, et al.
Publicado: (2011)

P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas
por: Rousso-Noori, Liat, et al.
Publicado: (2021)

MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR‐induced NF‐κB activation
por: Liu, Xuejiao, et al.
Publicado: (2020)

NF-κB Signalling in Glioblastoma
por: Soubannier, Vincent, et al.
Publicado: (2017)

Natural Small Molecules Targeting NF-κB Signaling in Glioblastoma
por: Uddin, Md. Sahab, et al.
Publicado: (2021)

NF-κB, Mesenchymal Differentiation and Glioblastoma
por: Yamini, Bakhtiar
Publicado: (2018)

Differentiated glioma cell-derived fibromodulin activates integrin-dependent Notch signaling in endothelial cells to promote tumor angiogenesis and growth
por: Sengupta, Shreoshi, et al.
Publicado: (2022)

CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy
por: Rosenblum, Daniel, et al.
Publicado: (2020)

Cytoskeletal Protein Palladin in Adult Gliomas Predicts Disease Incidence, Progression, and Prognosis
por: Mayer, Ori, et al.
Publicado: (2022)

Insulin Growth Factor-2 Binding Protein 3 (IGF2BP3) Is a Glioblastoma-specific Marker That Activates Phosphatidylinositol 3-Kinase/Mitogen-activated Protein Kinase (PI3K/MAPK) Pathways by Modulating IGF-2
por: Suvasini, Ramaswamy, et al.
Publicado: (2011)

P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression
por: Yeini, Eilam, et al.
Publicado: (2021)

Isoform-specific subcellular localization and function of protein kinase A identified by mosaic imaging of mouse brain
por: Ilouz, Ronit, et al.
Publicado: (2017)

Water-Soluble BODIPY Photocages with Tunable Cellular Localization
por: Kand, Dnyaneshwar, et al.
Publicado: (2020)

Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
por: Park, Mi Hee, et al.
Publicado: (2016)

Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway
por: Liu, Xuejiao, et al.
Publicado: (2020)

Molecular Mechanisms Regulating Temperature Compensation of the Circadian Clock
por: Narasimamurthy, Rajesh, et al.
Publicado: (2017)

KLF6 depletion promotes NF-κB signaling in glioblastoma
por: Masilamani, A P, et al.
Publicado: (2017)

Reciprocal Role of ERK and Nf-κb Pathways in Survival and Activation of Osteoclasts
por: Miyazaki, Tsuyoshi, et al.
Publicado: (2000)

Targeting Glioblastoma: The Current State of Different Therapeutic Approaches
por: Khan, Imran, et al.
Publicado: (2021)

Therapeutic effects of moxibustion simultaneously targeting Nrf2 and NF-κB in diabetic peripheral neuropathy
por: Li, Jia, et al.
Publicado: (2019)

Canonical NFκB signaling in myeloid cells is required for the glioblastoma growth
por: Achyut, B. R., et al.
Publicado: (2017)

IKK/NF-κB signaling contributes to glioblastoma stem cell maintenance
por: Rinkenbaugh, Amanda L., et al.
Publicado: (2016)

Meta-Analysis Identifies NF-κB as a Therapeutic Target in Renal Cancer
por: Peri, Suraj, et al.
Publicado: (2013)

NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus
por: Brightbill, Hans D., et al.
Publicado: (2018)

NF-κB Signaling in Targeting Tumor Cells by Oncolytic Viruses—Therapeutic Perspectives
por: Struzik, Justyna, et al.
Publicado: (2018)

TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα
por: Ji, Jianxiong, et al.
Publicado: (2020)

Targeting DNA Binding for NF-κB as an Anticancer Approach in Hepatocellular Carcinoma
por: Chung, Po Yee, et al.
Publicado: (2018)

Targeting AGTR1/NF-κB/CXCR4 axis by miR-155 attenuates oncogenesis in glioblastoma
por: Singh, Anukriti, et al.
Publicado: (2020)

NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways
por: Avci, Naze G., et al.
Publicado: (2020)

Evaluation of rs1957106 Polymorphism of NF-κBI in Glioblastoma Multiforme in Isfahan, Iran
por: Sadeghi, Yasaman, et al.
Publicado: (2019)

AEBP1 Promotes Glioblastoma Progression and Activates the Classical NF-κB Pathway
por: Guo, Kai, et al.
Publicado: (2020)

CDK1 is up-regulated by temozolomide in an NF-κB dependent manner in glioblastoma
por: Voce, David J., et al.
Publicado: (2021)

NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathway
por: Xiang, Jianyang, et al.
Publicado: (2022)

Silencing NUDT21 Attenuates the Mesenchymal Identity of Glioblastoma Cells via the NF-κB Pathway
por: Lou, Jia-Cheng, et al.
Publicado: (2017)

Glioblastoma Model Using Human Cerebral Organoids
por: Ogawa, Junko, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pbmfcdlbonphkcqip14gvol5v2